Zacks Investment ResearchWed, 20 May 2026 14:40:34 GMTCharles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?CRL+0.91%
Zacks Investment ResearchMon, 11 May 2026 14:16:24 GMTCharles River (CRL) Reliance on International Sales: What Investors Need to KnowCRL+0.91%
MarketBeatSat, 09 May 2026 23:05:20 GMTCharles River Laboratories International Q1 Earnings Call HighlightsCRL+0.91%
BenzingaFri, 08 May 2026 15:11:01 GMTThese Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 ResultsCRL+0.91%
Seeking AlphaThu, 07 May 2026 19:21:23 GMTCharles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call TranscriptCRL+0.91%
Seeking AlphaThu, 07 May 2026 16:26:07 GMTCharles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)CRL+0.91%
Zacks Investment ResearchThu, 07 May 2026 15:20:08 GMTCRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock DownCRL+0.91%
Zacks Investment ResearchThu, 07 May 2026 14:31:20 GMTCompared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key MetricsCRL+0.91%
Zacks Investment ResearchThu, 07 May 2026 13:56:18 GMTCharles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue EstimatesCRL+0.91%
Zacks Investment ResearchWed, 06 May 2026 14:15:44 GMTCharles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesCRL+0.91%
Zacks Investment ResearchTue, 28 Apr 2026 14:45:31 GMTHere's Why Charles River Laboratories (CRL) is a Strong Value StockCRL+0.91%
Zacks Investment ResearchTue, 14 Apr 2026 17:11:15 GMTWill Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?CRL+0.91%
Zacks Investment ResearchFri, 20 Mar 2026 16:31:36 GMTWhy Is Charles River (CRL) Down 6.8% Since Last Earnings Report?CRL+0.91%
Seeking AlphaTue, 10 Mar 2026 17:10:16 GMTCharles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptCRL+0.91%
Seeking AlphaTue, 03 Mar 2026 17:32:23 GMTCharles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference TranscriptCRL+0.91%
Zacks Investment ResearchTue, 24 Feb 2026 15:41:29 GMTWhy Charles River Laboratories (CRL) is a Top Value Stock for the Long-TermCRL+0.91%
Zacks Investment ResearchMon, 23 Feb 2026 15:16:53 GMTInvesting in Charles River (CRL)? Don't Miss Assessing Its International Revenue TrendsCRL+0.91%